Adverse events in people taking macrolide antibiotics versus placebo for any indication

Adverse events in people taking macrolide antibiotics versus placebo for any indication

<p><strong>BACKGROUND:</strong> Macrolide antibiotics (macrolides) are among the most commonly prescribed antibiotics worldwide and are used for a wide range of infections. However, macrolides also expose people to the risk of adverse events. The current understanding of adverse ev...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Hansen, M, Scott, A, McCullough, A, Thorning, S, Aronson, J, Beller, E, Glasziou, P, Hoffmann, T, Clark, J, Mar, D
Natura:	Journal article
Lingua:	English
Pubblicazione:	Cochrane Collaboration 2019

Documenti analoghi

Adverse events in patients taking cephalosporins versus placebo for any indication (protocol)
di: McCullough, A, et al.
Pubblicazione: (2016)

Addressing antibiotic resistance - focusing on acute respiratory infections in primary care.
di: Del Mar, C, et al.
Pubblicazione: (2012)

Placebo-Related Adverse Events in Rheumatoid Arthritis
di: Ratna Shree Sharma, et al.
Pubblicazione: (2022-02-01)

Macrolide antibiotic therapy in patients with cystic fibrosis
di: MH Schöni
Pubblicazione: (2003-05-01)

Administration of macrolide antibiotics increases cardiovascular risk
di: Yang Wu, et al.
Pubblicazione: (2023-02-01)

The evolution of substrate discrimination in macrolide antibiotic resistance enzymes
di: Andrew C. Pawlowski, et al.
Pubblicazione: (2018-01-01)

Addition of macrolide antibiotics for hospital treatment of community-acquired pneumonia
di: Wei, J, et al.
Pubblicazione: (2024)

Antibiotic resistance: what are the opportunities for primary care in alleviating the crisis?
di: Malene Plejdrup Hansen, et al.
Pubblicazione: (2015-02-01)

The scatter of research: cross sectional comparison of randomised trials and systematic reviews across specialties.
di: Hoffmann, T, et al.
Pubblicazione: (2012)

Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics
di: Helen C. Steel, et al.
Pubblicazione: (2012-01-01)

Inhibiting Effect of Macrolide Polyene Antibiotics on Reproduction of Viruses
di: A. A. Bagirova, et al.
Pubblicazione: (2020-05-01)

Context-specific action of macrolide antibiotics on the eukaryotic ribosome
di: Maxim S. Svetlov, et al.
Pubblicazione: (2021-05-01)

Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care
di: O'Sullivan, JW, et al.
Pubblicazione: (2016)

Association of Macrolide Resistance Genotypes and Synergistic Antibiotic Combinations for Combating Macrolide-Resistant MRSA Recovered from Hospitalized Patients
di: Amr S. Bishr, et al.
Pubblicazione: (2021-07-01)

Mechanism of Action of Macrolide Antibiotic Filipin on Cell and Lipid Membranes
di: A. A. Samedova, et al.
Pubblicazione: (2020-05-01)

Scaffold Modifications in Erythromycin Macrolide Antibiotics. A Chemical Minireview
di: Kjell Undheim
Pubblicazione: (2020-08-01)

Research on the treatment of Pseudomonas aeruginosa pneumonia in children by macrolide antibiotics
di: Huang Xu-qiang, et al.
Pubblicazione: (2015-01-01)

Genetic Variations and Antibiotic-Related Adverse Events
di: Nicola Principi, et al.
Pubblicazione: (2024-03-01)

Phenotypic Resistance of (MRSA) Clinical Isolates to Some Macrolide Antibiotic Groups
di: Ali Yaseen, et al.
Pubblicazione: (2023-12-01)

Molecular Imprinted Polymers for Macrolides, Aminoglycosides and Some Other Biosynthetic Antibiotics
di: M. I. Yakhkind, et al.
Pubblicazione: (2020-05-01)

In Vitro Impact of Macrolide Antibiotics on the Viability of Selected Mammalian Cell Lines
di: Eva Tvrdá, et al.
Pubblicazione: (2023-09-01)

Mechanisms of Resistance to Macrolide Antibiotics among <i>Staphylococcus aureus</i>
di: Maria Miklasińska-Majdanik
Pubblicazione: (2021-11-01)

Macrolide antibiotics activate the integrated stress response and promote tumor proliferation
di: Xin Yu, et al.
Pubblicazione: (2023-03-01)

Macrolide antibiotics and their place in therapy of upper respiratory tract infections therapy
di: A. Y. Ovchinnikov, et al.
Pubblicazione: (2016-12-01)

Differential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineage.
di: Carolina Aquilino, et al.
Pubblicazione: (2012-01-01)

Antibiotics for sore throat
di: Mar, D, et al.
Pubblicazione: (2000)

Clinical efficacy of macrolide antibiotics in mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients
di: Mengyuan He, et al.
Pubblicazione: (2024-07-01)

Adverse events in British hospitals. Retrospective case record analysis has been superseded.
di: Ferner, R, et al.
Pubblicazione: (2001)

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae
di: Hisanori Domon, et al.
Pubblicazione: (2023-06-01)

Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro
di: Toshikazu Shimane, et al.
Pubblicazione: (2001-01-01)

Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice
di: Hajime Terao, et al.
Pubblicazione: (2003-01-01)

Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens
di: Deepjyoti Paul, et al.
Pubblicazione: (2023-12-01)

Stress Degradation Studies of Macrolide Antibiotics “Roxithromycin, Tilmicosin and Tylosin” by Using HPLC
di: Bediha Akmese
Pubblicazione: (2020-03-01)

Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system
di: Skryabina A.A., et al.
Pubblicazione: (2023-03-01)

Understanding the role of antibiotic-associated adverse events in influencing antibiotic decision-making
di: Jerald P. Cherian, et al.
Pubblicazione: (2024-01-01)

A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study
di: Patrick M. Meyer Sauteur, et al.
Pubblicazione: (2024-10-01)

Discovery of the first macrolide antibiotic binding protein in Mycobacterium tuberculosis: a new antibiotic resistance drug target
di: Qingqing Zhang, et al.
Pubblicazione: (2018-01-01)

The crystal structure of two macrolide glycosyltransferases provides a blueprint for host cell antibiotic immunity.
di: Bolam, D, et al.
Pubblicazione: (2007)

Antibiotics for sore throat.
di: Mar, D, et al.
Pubblicazione: (2006)

Antibiotics for sore throat.
di: Mar, D, et al.
Pubblicazione: (2004)